Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6601263.pdf
Reference26 articles.
1. Aapro MS, Martin C, Hatty S (1998) Gemcitabine–a safety review. Anticancer Drugs 9: 191–201
2. Ahlgren JD (1996) Chemotherapy for pancreatic carcinoma. Cancer 78: 654–663
3. Burris III HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD, Andersen JS, Tarassoff PG, Brown TD, Casper ES (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. J Clin Oncol 15: 2403–2413
4. Carmichael J, Fink U, Russell RC, Spittle MF, Harris AL, Spiessi G, Blatter J (1996) Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer 73: 101–105
5. Cox D (1972) Regression models and life tables. J R Stat Soc [B] 34: 187–202
Cited by 142 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated with systemic chemotherapy;Annals of Medicine;2024-09-02
2. Analogues of the pan-selectin antagonist rivipansel (GMI-1070);European Journal of Medicinal Chemistry;2024-06
3. Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study);Cancer;2024-04-29
4. Pancreatic adenocarcinoma of the tail—Unveiling a rare presentation with venous thrombosis: A case report and literature review;SAGE Open Medical Case Reports;2024-01
5. Pancreatic Adenocarcinoma of the Tail: Unveiling a Rare Presentation with Venous Thrombosis: A Case Report and Comprehensive Literature Review;2023-12-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3